Interventional management of high-risk ACS and STEMI: don't just do it... do it right!

With an unrestricted educational grant from TERUMO and THE MEDICINES COMPANY

Learning Objectives

  • To appreciate the diversity and current management of ACS patients
  • To learn about the best synergies of the optimal procedural and pharmacological choices

Presentations available when logged in:

  • Interventional treatment of NSTEMI - The clock is also ticking!
  • From ESC guidelines to the cathlab - How well we do it in Europe?